Suppr超能文献

坦索罗辛用于远端输尿管结石伴肾绞痛药物排石治疗的疗效与安全性:一项多中心、随机、双盲、安慰剂对照试验

Efficacy and Safety of Tamsulosin in Medical Expulsive Therapy for Distal Ureteral Stones with Renal Colic: A Multicenter, Randomized, Double-blind, Placebo-controlled Trial.

作者信息

Ye Zhangqun, Zeng Guohua, Yang Huan, Tang Kun, Zhang Xiaochun, Li Hong, Li Weibing, Wu Zhong, Chen Lingwu, Chen Xingfa, Liu Xiankui, Deng Yaoliang, Pan Tiejun, Xing Jinchun, Wang Shusheng, Cheng Yue, Gu Xiaojian, Gao Wenxi, Yang Jianggen, Zhang Yonghai, Mi Qiwu, Qi Lin, Li Jiongming, Hu Weilie, Liang Peiyu, Sun Zhaolin, Xu Changbao, Long Yongfu, Liao Yongbin, Liu Siping, Liu Guoqing, Xu Xun, He Wei, Chen Zhiqiang, Xu Hua

机构信息

Department of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China; Hubei Institute of Urology, Wuhan, China.

The Center of Minimally-invasive Surgery, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.

出版信息

Eur Urol. 2018 Mar;73(3):385-391. doi: 10.1016/j.eururo.2017.10.033. Epub 2017 Nov 12.

Abstract

BACKGROUND

Recent large high-quality trials have questioned the clinical effectiveness of medical expulsive therapy using tamsulosin for ureteral stones.

OBJECTIVE

To evaluate the efficacy and safety of tamsulosin for distal ureteral stones compared with placebo.

DESIGN, SETTING, AND PARTICIPANTS: We conducted a double-blind, placebo-controlled study of 3296 patients with distal ureteral stones, across 30 centers, to evaluate the efficacy and safety of tamsulosin.

INTERVENTION

Participants were randomly assigned (1:1) into tamsulosin (0.4mg) or placebo groups for 4 wk.

OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS

The primary end point of analysis was the overall stone expulsion rate, defined as stone expulsion, confirmed by negative findings on computed tomography, over a 28-d surveillance period. Secondary end points included time to stone expulsion, use of analgesics, and incidence of adverse events.

RESULTS AND LIMITATIONS

Among 3450 patients randomized between September 1, 2011, and August 31, 2013, 3296 (96%) were included in the primary analysis. Tamsulosin benefits from a higher stone expulsion rate than the placebo (86% vs 79%; p<0.001) for distal ureteral stones. Subgroup analysis identified a specific benefit of tamsulosin for the treatment of large distal ureteral stones (>5mm). Considering the secondary end points, tamsulosin-treated patients reported a shorter time to expulsion (p<0.001), required lower use of analgesics compared with placebo (p<0.001), and significantly relieved renal colic (p<0.001). No differences in the incidence of adverse events were identified between the two groups.

CONCLUSIONS

Our data suggest that tamsulosin use benefits distal ureteral stones in facilitating stone passage and relieving renal colic. Subgroup analyses find that tamsulosin provides a superior expulsion rate for stones >5mm, but no effect for stones ≤5mm.

PATIENT SUMMARY

In this report, we looked at the efficacy and safety of tamsulosin for the treatment of distal ureteral stones. We find that tamsulosin significantly facilitates the passage of distal ureteral stones and relieves renal colic.

摘要

背景

近期大规模高质量试验对使用坦索罗辛进行药物排石疗法治疗输尿管结石的临床疗效提出了质疑。

目的

比较坦索罗辛与安慰剂治疗远端输尿管结石的疗效和安全性。

设计、地点和参与者:我们在30个中心对3296例远端输尿管结石患者进行了一项双盲、安慰剂对照研究,以评估坦索罗辛的疗效和安全性。

干预措施

参与者被随机(1:1)分为坦索罗辛(0.4mg)组或安慰剂组,为期4周。

结局测量和统计分析

分析的主要终点是总体结石排出率,定义为在28天的监测期内通过计算机断层扫描阴性结果确认的结石排出。次要终点包括结石排出时间、镇痛药的使用情况和不良事件的发生率。

结果和局限性

在2011年9月1日至2013年8月31日期间随机分组的3450例患者中,3296例(96%)纳入主要分析。对于远端输尿管结石,坦索罗辛的结石排出率高于安慰剂(86%对79%;p<0.001)。亚组分析确定坦索罗辛对治疗大型远端输尿管结石(>5mm)有特定益处。考虑次要终点,坦索罗辛治疗的患者报告排出时间较短(p<0.001),与安慰剂相比镇痛药使用较少(p<0.001),并且显著缓解肾绞痛(p<0.001)。两组之间未发现不良事件发生率的差异。

结论

我们的数据表明,使用坦索罗辛有利于远端输尿管结石的排出并缓解肾绞痛。亚组分析发现,坦索罗辛对>5mm的结石排出率更高,但对≤5mm的结石无效。

患者总结

在本报告中,我们研究了坦索罗辛治疗远端输尿管结石的疗效和安全性。我们发现坦索罗辛显著促进远端输尿管结石的排出并缓解肾绞痛。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验